GlassScriptPhysician profile
Joseph Rabe
NPI 1407241474
$35,953.00
in general payments reported to CMS, 2019-2025
6 companies · $777 in 2025
The $777 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11K · 2021: $18K · 2022: $3,351 · 2023: $2,511 · 2024: $18.36 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,329 · Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,329.06 |
| Food and Beverage | $977.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21,917.61 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Evos, Bone Anchors With Arthroscopic Delivery System |
| Arthrex, INC. | $9,010.57 | 2021-2025 | |
| Rock Medical Orthopedics, INC. | $4,793.87 | 2020-2024 | |
| Pylant Medical | $145.83 | 2023 | |
| Stryker Corporation | $48.26 | 2025 | Hoffmann, Gamma |
| Nexus Medical Technologies LLC | $36.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.